Interaction between periodontal disease and atherosclerotic vascular disease--Fact or fiction?

Atherosclerosis. 2015 Aug;241(2):555-60. doi: 10.1016/j.atherosclerosis.2015.04.819. Epub 2015 May 5.

Abstract

C-reactive protein (CRP) level is associated with the 10-year risk of an atherosclerotic vascular disease (ASVD), suggesting presence of systemic inflammation probably long before ASVD is present. Where, however, does this systemic inflammation come from? One active area of research has been the study of dental infection and various forms of periodontal disease (PD), both of which are highly prevalent in populations at risk for ASVD. Recent data show that ASVD and PD interact with each other via systemic release of specific pro- and anti-inflammatory cytokines, small signal molecules and enzymes which modulate initiation and progression of the chronic inflammatory reaction involved in both diseases. In addition, periodontal pathogens were identified within atherosclerotic lesions and thrombi isolated from myocardial infarction patients. LDL cholesterol, a strong risk factor for ASVD, is also associated with PD; and statins, used to treat ASVD, are also active to prevent or reduce PD. Finally, there is growing evidence for common genetic susceptibility factors involved in both diseases. These findings support commonalities with respect to the pathogenic mechanisms involved in both inflammatory diseases. Conversely, a causative relationship cannot yet be concluded in the absence of data from large longitudinal cohort and randomized controlled intervention trials.

Keywords: CHD risk; Chronic inflammation; Epidemiology; Genetic predisposition; Myocardial infarction; Periodontal disease; Stroke risk.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / complications*
  • Atherosclerosis / microbiology
  • Biomarkers / metabolism
  • C-Reactive Protein / metabolism
  • Cholesterol, LDL / blood
  • Comorbidity
  • Disease Models, Animal
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / blood
  • Inflammation
  • Periodontal Diseases / complications*
  • Periodontal Diseases / microbiology
  • Research Design
  • Risk
  • Vascular Diseases / complications
  • Vascular Diseases / microbiology

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • C-Reactive Protein